SEATTLE, WA--(MARKET WIRE)--Sep 13, 2007 -- Targeted Genetics Corporation (NasdaqCM:TGEN - News) will report on the proceedings of the Recombinant DNA Advisory Committee (RAC) and the Company's tgAAC94 clinical program in inflammatory arthritis following the meeting on September 17, 2007.
